(Q44016842)

29 November 2017

title

Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease (English)

1 reference

29 November 2017

Klaus A Dugi

1

1 reference

29 November 2017

Nikolaus Schmidt

2

1 reference

29 November 2017

Karin Brandauer

3

1 reference

29 November 2017

Dirk Ramacher

4

1 reference

29 November 2017

Walter Fiehn

5

1 reference

29 November 2017

Joerg Kreuzer

6

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

163

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

127-134

1 reference

Functional variants in the lipoprotein lipase gene and risk cardiovascular disease

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Association of lipoprotein lipase gene polymorphisms with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Antiatherogenic effects of a novel lipoprotein lipase-enhancing agent in cholesterol-fed New Zealand white rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Atherogenesis: a postprandial phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Lipoprotein lipase can function as a monocyte adhesion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Lipoprotein Lipase (LPL) Strongly Links Native and Oxidized Low Density Lipoprotein Particles to Decorin-coated Collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Lipoprotein lipase secretion by human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

A more meaningful scoring system for determining the severity of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the li

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Post-heparin lipases, lipids and related hormones in men undergoing coronary arteriography to assess atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Progression and regression of human coronary atherosclerosis The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Effect of hepatic lipase on LDL in normal men and those with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Postprandial lipoproteins and progression of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Depletion of lipoprotein lipase after heparin administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

Familial combined hyperlipidemia and abnormal lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900752-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(01)00752-3

1 reference

29 November 2017

1 reference